Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Molecular characterization of primary lymphomas of the central nervous system towards a better prediction of evolution and personalized treatments

Published on: 07/12/2022 Reading time: 1 min
image

Researchers and clinicians from the research team co-directed by Prof. Marc SANSON and Emmanuelle HUILLARD at the Paris Brain Institute have just identified four molecular profiles of primary central nervous system lymphoma (PCNSL) that could predict the disease evolution and the risk of recurrence, allowing to orient patient care towards more effective therapies.

Primary central nervous system lymphomas

Primary central nervous system lymphomas are characterized by the proliferation of B lymphocytes, immune cells whose role is to defend the body against viruses and bacteria.

PNSCLs develop in the brain, meninges (membranes surrounding the brain), spinal cord and eyes and account for 5% of malignant brain tumors.

These tumors affect 400 new people each year and there is an increase in the number of new cases in the elderly, with those over 60 years of age accounting for over 70% of cases.

The diagnosis of these tumors is based on brain imaging and the dosage of an interleukin, an immune molecule in the cerebrospinal fluid associated with clinical symptoms such as cognitive and behavioral disorders, and signs of intracranial hypertension. Nevertheless, clinical and radiological features presented by patients are very heterogeneous leading to diagnosis difficulties.

 

A diagnosis and therapeutic orientation assistance

The work of Agusti ALENTORN, a neurologist and researcher in the "GENETICS AND DEVELOPMENT OF BRAIN TUMORS" team, aimed to define molecular profiles to help in the diagnosis and to establish an earlier adapted therapeutic management. The study involved the analysis of brain tissues from 250 patients with CNSPA associated with clinical and radiological criteria.

The joint analysis of these data lead to identify four specific patient profiles associated with a prognosis of more or less severe and rapid evolution. These results, published in the prestigious journal Annals of Oncology, will allow to better evaluate each patient with LPSNC, thus reducing the time to diagnosis and allowing for earlier and more targeted therapy.

Sources

Ann Oncol. 2022 Nov 16:S0923-7534(22)04732-9. doi: 10.1016/j.annonc.2022.11.002. Epub ahead of print. PMID: 36402300.

landscape AI
Team
Genetics and Brain Tumour Development

The objective of the "Genetics and Development of Brain Tumours" team is to identify new genetic mutations and biomarkers of brain tumours, as well as to understand the cellular and molecular mechanisms involved in their development.

Read more

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news